Kyle V, Silverman B, Silman A, King H, Oswald N, Reiss B, Hazleman B
Br Med J (Clin Res Ed). 1985 Aug 10;291(6492):385-7. doi: 10.1136/bmj.291.6492.385.
The aim of this study was to establish the incidence and prevalence of polymyalgia rheumatica/giant cell arteritis in general practice. Patients with this disorder, whether previously diagnosed or not, were ascertained by using a questionnaire administered by interview, and all received full clinical and laboratory assessment. A total of 579 patients aged 65 and over was seen, and 19 (33/1000) had been diagnosed or developed symptoms within the previous eight years. Thus the calculated annual incidence in those aged 65 and over was about 4/1000. The figures from this first large scale study of polymyalgia rheumatica/giant cell arteritis in general practice are much higher than those from studies carried out in hospital. The questionnaire was effective in both identifying known cases of polymyalgia rheumatica/giant cell arteritis and detecting new cases. As this is a treatable disorder, it is important that doctors become aware of how common it is in elderly people.
本研究的目的是确定全科医疗中风湿性多肌痛/巨细胞动脉炎的发病率和患病率。通过访谈问卷的方式确定患有这种疾病的患者,无论之前是否被诊断过,所有患者均接受了全面的临床和实验室评估。共诊治了579名65岁及以上的患者,其中19名(每1000人中有33名)在过去八年中被诊断出或出现了相关症状。因此,65岁及以上人群的计算年发病率约为每1000人中有4名。这项在全科医疗中首次对风湿性多肌痛/巨细胞动脉炎进行的大规模研究所得出的数据,远高于在医院进行的研究数据。该问卷在识别已知的风湿性多肌痛/巨细胞动脉炎病例以及检测新病例方面均有效。由于这是一种可治疗的疾病,医生了解其在老年人中的常见程度非常重要。